Table 4.

Comparison of HIF-1α, Wnt1, β-catenin, α-SMA, and E-cadherin levels (M ± SD).

Variable		Treatment group	Control group	t	P
HIF-1α(ng/ml)	pre	1.71±0.33	1.76±0.31	-0.672	0.504
	post	0.66±0.16	1.39±0.17	19.846	≤0.001
Wnt1(pg/ml)	pre	378.2±88.0	382.5±85.4	-0.224	0.823
	post	314.2±85.8	382.8±85.3	-3.584	=0.001
β-catenin(pg/ml)	pre	462.6±13.6	461.7±16.7	0.266	0.719
	post	416.5±13.6	462.1±15.1	-14.176	≤0.001
α-SMA(KU/L)	pre	25.9±4.6	26.2±5.0	-0.279	0.781
	post	20.5±3.1	23.5±4.1	-3.754	≤0.001
E-cadherin(ng/ml)	pre	2553.5±404.4	2520.2±505.7	0.013	0.897
	post	2166.9±398.6	2370.7±468.0	-2.097	0.039